Psychedelic Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Market Report Covers Global Biggest Psychedelics Companies and is Segmented by Drug Type (Gamma Hydroxybutyric Acid (GHB), Ketamine, Psilocybin, Lysergic Acid Diethylamide (LSD), 3, 4-MethylEnedioxyMethamphetamine, Other Drug Types), Application (Treatment-Resistant Depression, Opiate Addiction, Post-Traumatic Stress Disorder, Narcolepsy, and Panic Disorder, Other Applications), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Distribution Channel), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The Value is Provided in (USD Million) for the Above Segments.

Psychedelic Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Psychedelic Drugs Industry Overview

The psychedelic drugs market is consolidated in nature and consists of several major players. A few major players are currently dominating the market in terms of market share. Some companies currently dominating the market include Jazz Pharmaceuticals, PharmaTher Holdings Ltd, Celon Pharmaceuticals, Cybin Corp, and Pfizer Inc., which hold substantial market shares.

Psychedelic Drugs Market Leaders

  1. Celon Pharmaceuticals

  2. Cybin Corp

  3. Pfizer Inc

  4. Jazz Pharmaceuticals, Inc.

  5. PharmaTher Holdings Ltd

  6. *Disclaimer: Major Players sorted in no particular order
Psychedelic Drugs Market Concentration